February 7, 2017
Corium to Present at Upcoming Investor Conferences
MENLO PARK, Calif. , Feb. 07, 2017 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Peter Staple , Corium’s President and…